Readystate Asset Management LP Purchases Shares of 34,173 Healthpeak Properties, Inc. $DOC

Readystate Asset Management LP acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the second quarter, HoldingsChannel.com reports. The firm acquired 34,173 shares of the real estate investment trust’s stock, valued at approximately $731,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp raised its position in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after buying an additional 2,438,278 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares during the period. Geode Capital Management LLC grew its stake in Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares during the last quarter. Finally, Invesco Ltd. grew its stake in Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after buying an additional 1,648,012 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $20.65 on Tuesday. The company’s 50 day simple moving average is $21.53 and its 200 day simple moving average is $19.37. The stock has a market capitalization of $14.24 billion, a price-to-earnings ratio of 59.00, a price-to-earnings-growth ratio of 2.55 and a beta of 1.01. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.95.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts predict that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Wall Street Analysts Forecast Growth

DOC has been the subject of several research reports. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, August 19th. UBS Group upped their target price on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. JPMorgan Chase & Co. increased their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. BMO Capital Markets lifted their price target on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Finally, Wells Fargo & Company boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $21.72.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.